Center for Infectious Disease Research Policy (CIDRAP) has released a draft of its research and development (R&D) roadmaps for Ebola/Marburg, Lassa fever, and Nipah for public feedback this week.
CIDRAP, with support from the GloPID-R member Wellcome Trust and in collaboration with WHO, an observer in GloPID-R, has been tasked with facilitating the collaborative development of the R&D Roadmaps.
The roadmap prioritizes the development of countermeasures (diagnostics, therapeutics and vaccines) that are most needed by Ebola/Marburg, Lassa fever, and Nipah-affected countries and is the result of extensive consultations with associated taskforces, leading national and international experts and other key stakeholders.
CIDRAP plans to host a series of one-hour webinars to provide information about the R&D roadmap development process and the three draft R&D roadmap documents. The goal is to facilitate engagement in the review process with a broad range of stakeholders.
Through these webinars, participants will have an opportunity to view brief presentations on each priority disease roadmap and ask written questions via an online Q&A process.
- Ebola/Marburg: Tuesday, May 15, 2018 – 9:30 am Central Daylight Time (CDT) (3:30 pm British Summer Time [BST] / 4:30 pm Central European Summer Time [CEST])
- Lassa: Wednesday, May 16, 2018 – 9:30 am CDT (3:30 pm BST / 4:30 pm CEST)
- Nipah: Tuesday, May 15, 2018 – 8:00 pm CDT (Wednesday, May 16 at 2:00 am BST / 3:00 am CEST / 7:00 am Bangladesh Standard Time / 9:00 am Singapore Time)
- Nipah: Tuesday, May 22, 2018 – 9:30 am CDT (3:30 pm BST / 4:30 pm CEST)